<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02003404</url>
  </required_header>
  <id_info>
    <org_study_id>5642-O</org_study_id>
    <secondary_id>LUHSC IRB #: 205654091813</secondary_id>
    <nct_id>NCT02003404</nct_id>
  </id_info>
  <brief_title>Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin</brief_title>
  <official_title>Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hollister Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Loyola University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hollister Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This purpose of this study is to look at three commercially available ostomy barriers on
      peristomal (around the stoma) skin. Repeated barrier application and removal over years
      causes changes to the skin that the investigators wish to investigate. The primary objective
      is to measure peel force on normal skin and peel force on peristomal skin, with the intent of
      determining if differences occur. The study hypotheses is that no differences exist.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, non-invasive exploratory study utilizing a sample of convenience.
      This study compares three commercially available barrier materials on peristomal skin and
      normal abdominal skin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Barrier Peel Force</measure>
    <time_frame>4 hours</time_frame>
    <description>Peel force of barrier materials, comparing peristomal skin to abdominal skin. A portable peel force analyser, previously validated, was used in the clinic to measure peel at 90 degrees to the plane of the body. Peel force was measured on peristomal skin and ipsilateral abdominal skin in the same subject.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Dermatologic Complications</condition>
  <arm_group>
    <arm_group_label>Control Abdominal Skin</arm_group_label>
    <description>Apply SoftFlex (standard wear commercial skin barrier), FlexWear (standard wear commercial skin barrier), and FlexTend (extended wear commercial skin barrier), material to non-peristomal abdominal skin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peristomal Abdominal Skin</arm_group_label>
    <description>Apply SoftFlex, FlexWear and FlexTend barrier material to peristomal abdominal skin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control Abdominal Skin</intervention_name>
    <description>Three barrier materials will be peeled from abdominal skin after a set period at a set rate.</description>
    <arm_group_label>Control Abdominal Skin</arm_group_label>
    <other_name>SoftFlex</other_name>
    <other_name>FlexWear</other_name>
    <other_name>FlexTend</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Peristomal Abdominal Skin</intervention_name>
    <description>Three barrier materials will be peeled from abdominal skin after a set period at a set rate.</description>
    <arm_group_label>Peristomal Abdominal Skin</arm_group_label>
    <other_name>SoftFlex</other_name>
    <other_name>FlexWear</other_name>
    <other_name>FlexTend</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ostomates with a normal peristomal skin and normal ipsilateral abdominal skin
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Colostomy, Ileostomy, or Urostomy patients at least 6 months post-surgery

          -  Males or females, age 18 to 80 years old at the time of enrollment

          -  Body Mass Index (BMI) between 18 and 50

          -  Willing to have two approximately 5&quot; x 5&quot; areas of the abdomen trimmed with a surgical
             clipper -- one in a ring around the stoma, and one on the opposite side

          -  Willing to remain within the testing room for the duration of the study

          -  Willing to allow a third person in the room as a witness for the duration of the study

          -  Able to position oneself onto and off of the examining table without the assistance of
             the Investigator

          -  Willing to refrain from vigorous exercise for the duration of the study

          -  Willing to not take any anti-inflammatory medications (except for
             Tylenol/acetaminophen) starting 48 hours prior to the study and for the duration of
             the study

          -  Willing to bring an extra barrier and replace their barrier worn during the study.

          -  Willing to follow the protocol as demonstrated by signing the Informed Consent Form

          -  In the opinion of the Investigator or qualified site personnel is qualified to
             participate

        Exclusion Criteria:

          -  Clinically significant diseases, which may or may not be confined to the testing site,
             that may contraindicate participation; including but not limited to psoriasis, eczema,
             atopic dermatitis, and active cancer

          -  Use of topical drugs on the application site within 1 month.

          -  Use of lotions, creams, powders or oils on the application site in the 24 hours prior
             to application

          -  Pregnancy, lactation or planning a pregnancy as determined by interview only

          -  Other medical conditions, for example uncontrolled diabetes, which in the
             Investigator's judgment, makes the subject ineligible or places the subject at undue
             risk

          -  Participation in any clinical test either using the abdomen as a test site or using
             systemic therapy within the previous thirty days

          -  Damaged skin or other skin conditions in or near test sites which includes sunburn,
             scars, numerous moles or other disfiguration of the test site

          -  Significant adipose tissue at the test site that would preclude adequate adhesion of
             the study devices

          -  Known allergy to any of the test materials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Swan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loyola University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>La Grange Center for Health</name>
      <address>
        <city>La Grange Park</city>
        <state>Illinois</state>
        <zip>60526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2013</study_first_submitted>
  <study_first_submitted_qc>December 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2013</study_first_posted>
  <results_first_submitted>September 15, 2014</results_first_submitted>
  <results_first_submitted_qc>September 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 19, 2015</results_first_posted>
  <last_update_submitted>October 5, 2016</last_update_submitted>
  <last_update_submitted_qc>October 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ostomy appliance</keyword>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>All 17 participants wore all three barrier types on control area AND peristomal area NOT 34 participants in study only 17 participants in study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Abdominal Skin Barrier Peel Force</title>
          <description>Barrier materials were attached and peeled off control and peristomal abdominal skin.
Three commercial barrier materials (SoftFlex, FlexWear and FlexTend) were peeled from control or peristomal abdominal skin after a set period at a set rate.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Must have ostomy of any type.</population>
      <group_list>
        <group group_id="B1">
          <title>Abdominal Skin Barrier Peel Force</title>
          <description>Three commerical barrier materials, SoftFlex, FlexWear and FlexTend barrier were peeled from control or peristomal abdominal skin after a set period at a set rate.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Skin Barrier Peel Force</title>
        <description>Peel force of barrier materials, comparing peristomal skin to abdominal skin. A portable peel force analyser, previously validated, was used in the clinic to measure peel at 90 degrees to the plane of the body. Peel force was measured on peristomal skin and ipsilateral abdominal skin in the same subject.</description>
        <time_frame>4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Abdominal Skin Barrier Peel Force</title>
            <description>Three commerical barrier materials, SoftFlex, FlexWear and FlexTend FlexWear barrier were peeled from abdominal skin after a set period at a set rate.</description>
          </group>
          <group group_id="O2">
            <title>Peristomal Skin Barrier Peel Force</title>
            <description>Three commerical barrier materials, SoftFlex, FlexWear and FlexTend FlexWear barrier were peeled from peristomal skin after a set period at a set rate.</description>
          </group>
        </group_list>
        <measure>
          <title>Skin Barrier Peel Force</title>
          <description>Peel force of barrier materials, comparing peristomal skin to abdominal skin. A portable peel force analyser, previously validated, was used in the clinic to measure peel at 90 degrees to the plane of the body. Peel force was measured on peristomal skin and ipsilateral abdominal skin in the same subject.</description>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150" spread="10"/>
                    <measurement group_id="O2" value="215" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>5 months. Period from Sept 1, 2013 to Jan 31, 2014.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control Abdominal Skin Barrier Peel Force</title>
          <description>Three commerical barrier materials, SoftFlex, FlexWear and FlexTend FlexWear barrier were peeled from abdominal skin after a set period at a set rate.</description>
        </group>
        <group group_id="E2">
          <title>Peristomal Skin Barrier Peel Force</title>
          <description>Three commerical barrier materials, SoftFlex, FlexWear and FlexTend FlexWear barrier were peeled from peristomal skin after a set period at a set rate.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size may not be generalizable to the population.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr James Swan, MD</name_or_title>
      <organization>Loyola University of Chicago</organization>
      <phone>708-485-1271</phone>
      <email>jswan@lumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

